NO942532L - Fremgangsmåte og anvendelser for 4,5-diydrogeldanamycin og dets hydrokinon - Google Patents

Fremgangsmåte og anvendelser for 4,5-diydrogeldanamycin og dets hydrokinon

Info

Publication number
NO942532L
NO942532L NO942532A NO942532A NO942532L NO 942532 L NO942532 L NO 942532L NO 942532 A NO942532 A NO 942532A NO 942532 A NO942532 A NO 942532A NO 942532 L NO942532 L NO 942532L
Authority
NO
Norway
Prior art keywords
diydrogeldanamycin
hydroquinone
Prior art date
Application number
NO942532A
Other languages
English (en)
Other versions
NO942532D0 (no
Inventor
Walter P Cullen
Mark T Jefferson
Mikel P Moyer
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO942532D0 publication Critical patent/NO942532D0/no
Publication of NO942532L publication Critical patent/NO942532L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
NO942532A 1992-01-06 1994-07-05 Fremgangsmåte og anvendelser for 4,5-diydrogeldanamycin og dets hydrokinon NO942532L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81723592A 1992-01-06 1992-01-06
PCT/US1992/010189 WO1993014215A1 (en) 1992-01-06 1992-12-03 Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone

Publications (2)

Publication Number Publication Date
NO942532D0 NO942532D0 (no) 1994-07-05
NO942532L true NO942532L (no) 1994-07-05

Family

ID=25222638

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942532A NO942532L (no) 1992-01-06 1994-07-05 Fremgangsmåte og anvendelser for 4,5-diydrogeldanamycin og dets hydrokinon

Country Status (15)

Country Link
JP (1) JPH06510913A (no)
KR (1) KR940703923A (no)
CN (1) CN1074937A (no)
AU (1) AU3225693A (no)
BR (1) BR9207024A (no)
CA (1) CA2127457A1 (no)
CZ (1) CZ390592A3 (no)
FI (1) FI943207A (no)
HU (1) HU9401936D0 (no)
IL (1) IL104289A0 (no)
MX (1) MX9300011A (no)
NO (1) NO942532L (no)
PT (1) PT101169A (no)
WO (1) WO1993014215A1 (no)
ZA (1) ZA9333B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2794342B2 (ja) * 1993-06-29 1998-09-03 ファイザー・インク． 抗癌遺伝子剤および抗癌剤としてのアンサマイシン誘導体
US5932566A (en) * 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US6852496B1 (en) 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
US6872715B2 (en) * 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
KR20040054692A (ko) 2001-09-24 2004-06-25 콘포마 세러퓨틱스 코포레이션 17-알릴 아미노 겔다나마이신 (17-ａａｇ) 및 기타안사마이신의 제조 방법
EP1923061A1 (en) 2001-09-24 2008-05-21 Conforma Therapeutic Corporation Process for preparing 17-Allyl amino geldanamycin (17-AAG) and other ansamycins
US7465718B2 (en) 2002-02-08 2008-12-16 Conforma Therapeutics Corporation Ansamycins having improved pharmacological and biological properties
TW200303363A (en) * 2002-02-25 2003-09-01 Upjohn Co Process to prepare and isolate geldanamycin
WO2005009345A2 (en) 2003-06-13 2005-02-03 Kosan Biosciences, Inc. 2-desmethyl ansamycin compounds
US6887993B1 (en) 2003-11-12 2005-05-03 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6875863B1 (en) 2003-11-12 2005-04-05 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6855705B1 (en) 2003-11-12 2005-02-15 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
EP1682514A4 (en) 2003-11-12 2008-07-16 Kosan Biosciences Inc 11-O-METHYLGELDANAMYCIN COMPOUNDS
EP1689436A1 (en) * 2003-11-26 2006-08-16 Entelos, Inc. TREATMENT OF RHEUMATOID ARTHRITIS WITH HYPOXIA-INDUCIBLE FACTOR a ANTAGONISTS
US7282493B2 (en) * 2003-12-23 2007-10-16 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
ZA200604863B (en) * 2003-12-23 2007-12-27 Infinity Pharmaceuticals Inc Analogs of benzoquinone-containing ansamycins for the treatment of cancer
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
NZ561939A (en) 2005-03-30 2011-03-31 Conforma Therapeutics Corp Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors
ES2389740T3 (es) * 2006-11-09 2012-10-31 Bristol-Myers Squibb Company Nuevos compuestos y procedimientos para su producción
PE20081506A1 (es) 2006-12-12 2008-12-09 Infinity Discovery Inc Formulaciones de ansamicina
CN100500668C (zh) * 2006-12-19 2009-06-17 中国人民解放军军事医学科学院毒物药物研究所 格尔德霉素衍生物及其制备方法和制备药物的用途
EP2121957A4 (en) 2007-01-26 2010-11-10 Kosan Biosciences Inc MACROLACTAMES OBTAINED BY MODIFIED BIOSYNTHESIS
US20110034686A1 (en) * 2008-04-21 2011-02-10 Nitin Sopanrao Patil Process for Isolation and Purification of Geldanamycin
CN102245021B (zh) 2008-10-15 2014-09-17 无限药品公司 安莎霉素氢醌组合物
CN102030764B (zh) * 2010-11-12 2012-07-04 中国医学科学院医药生物技术研究所 4，5双氢噻嗪酮格尔德霉素及其制备方法
CN103305563B (zh) * 2013-06-14 2014-12-03 湖南农业大学 一种以链霉菌提制阿里沙霉素的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595955A (en) * 1969-03-26 1971-07-27 Upjohn Co Geldanamycin and process for producing same

Also Published As

Publication number Publication date
FI943207A0 (fi) 1994-07-05
KR940703923A (ko) 1994-12-12
PT101169A (pt) 1994-03-31
MX9300011A (es) 1993-12-01
FI943207A (fi) 1994-07-05
NO942532D0 (no) 1994-07-05
CA2127457A1 (en) 1993-07-22
HU9401936D0 (en) 1994-09-28
BR9207024A (pt) 1995-12-05
CN1074937A (zh) 1993-08-04
JPH06510913A (ja) 1994-12-08
ZA9333B (en) 1994-07-05
CZ390592A3 (en) 1993-08-11
IL104289A0 (en) 1993-05-13
WO1993014215A1 (en) 1993-07-22
AU3225693A (en) 1993-08-03

Similar Documents

Publication Publication Date Title
NO942532L (no) Fremgangsmåte og anvendelser for 4,5-diydrogeldanamycin og dets hydrokinon
KR950701061A (ko) 방탄제품 및 이의 제조방법(Ballistic-resistane articlt and process for making the same)
EP0589675A3 (en) BiCDMOS manufacturing technology and its structures.
NO931326D0 (no) Komposittprodukt og fremgangsmaate til fremstilling derav
DK0519573T3 (da) Hydrogenerings-katalysator og fremgangsmåde
NO20035726D0 (no) Benzopyran-inneholdende forbindelser og fremgangsmåte for anvendelse derav
DE69402198D1 (de) Hartlötverfahren
NO965489D0 (no) Kontrollert denitrifikasjonsprosess og system
DE69332992D1 (de) Hocheffizientes Kodierverfahren
GB2274080B (en) Ceiling runners and process for producing same
DE69313022D1 (de) Verflüssigungsverfahren
DE69401016D1 (de) Biegverfahren und -gerät
DE69202041D1 (de) Tiefgefriervorrichtung und -verfahren.
DE69423875T2 (de) Hydrodealkylierungsverfahren
EP0638357A3 (de) Vorrichtung zur kontinuierlichen Herstellung von Polyacetalen und ihre Verwendung.
NO954207D0 (no) Preparat inneholdende kolestyramin og fremgangsmåte for dets fremstilling
DE69417308D1 (de) Decarboxylierungsverfahren
NO952097D0 (no) Fremgangsmåte og anlegg for törking og etterfölgende spalting
NO941134D0 (no) 1,2,5,6-tetrahydropyridin-derivat, fremgangsmåte for dets fremstilling, og dets terapeutiske anvendelser
DK0853606T3 (da) 1,1-difluor-1,4-dichlorbutan og fremgangsmåde til dets fremstilling
DE69309870T2 (de) Drehverfahren
KR950701012A (ko) 금속을 처리하기 위한 조성물 및 방법(composition and process for treating metal)
NO932638L (no) 21-klor-pregnanderivat og fremgangsmaater for dets fremstilling
EP0601351A3 (en) N-(2-sulphatoethyl)piperazine-sulphate and process for the production thereof.
NO951033D0 (no) Smeltebearbeidbar blokk-kopolyesterimid og fremgangsmåte for fremstilling derav